MicroTech Medical (Hangzhou) Co., Ltd.

Equities

2235

CNE100004QN6

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:20 2024-04-16 am EDT 5-day change 1st Jan Change
4 HKD -2.44% Intraday chart for MicroTech Medical (Hangzhou) Co., Ltd. -2.44% -37.50%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
MicroTech Medical Co., Ltd. Appoints Shi Yonghui as Joint Company Secretary CI
MicroTech Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Microtech Medical Co., Ltd Announces Resignation of Duo Bo as Joint Company Secretary CI
Microtech Medical Co., Ltd. Announces Committee Changes CI
MicroTech Medical Co., Ltd. commences an Equity Buyback Plan for 17,384,044 shares, representing 4.08% of its issued share capital, under the authorization approved on May 18, 2023. CI
MicroTech Medical Co., Ltd. Announces Change of Joint Company Secretary CI
MicroTech Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
MicroTech Medical Completes Conversion to H Shares MT
MicroTech Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
MicroTech Medical Gets Regulatory Nod to Convert 3.5 Million Domestic Shares into Hong Kong Shares MT
Microtech Medical Co., Ltd. Announces Executive Changes CI
Microtech Medical Co., Ltd. Announces Executive Changes CI
Certain H Shares of MicroTech Medical Co., Ltd. are subject to a Lock-Up Agreement Ending on 18-OCT-2022. CI
MicroTech Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Certain H Shares of MicroTech Medical Co., Ltd. are subject to a Lock-Up Agreement Ending on 18-APR-2022. CI
MicroTech Medical's Diabetes Detection Product Qualified for Launch in China MT
MicroTech Medical Raises over $8 Million from Partial Exercise of Hong Kong IPO's Overallotment Option MT
MicroTech Medical's Glucose Monitoring Device Wins Marketing Approval in China MT
Microtech Medical Co., Ltd. Announces Approval of the Continuous Glucose Monitoring System Device for Marketing CI
Hang Seng : Hong Kong Stocks Hit Five-Week High; MicroTech Medical Ends Flat in Debut MT
MicroTech Medical Hangzhou : Shares Up 2% in Hong Kong Debut, Breaks String of Weak First-Day Trading Since July MT
MicroTech Medical Co., Ltd. has completed an IPO in the amount of HKD 1.93765 billion. CI
MicroTech Medical : Raises $234 Million in Tencent-Backed Hong Kong IPO Ahead of Tuesday Debut MT
MicroTech Medical Co., Ltd. has filed an IPO in the amount of HKD 1.978944 billion. CI
MicroTech Medical Co., Ltd. announced that it has received CNY 575 million in funding from a group of investors CI
Chart MicroTech Medical (Hangzhou) Co., Ltd.
More charts
MicroTech Medical Hangzhou Co Ltd is a China-based company that mainly engaged in research, production and commercialization of diabetes treatment and diabetes monitoring. The Company's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The Company's products, such as artificial pancreas, are in the process of research and development. The Company's products are sold to overseas markets such as the United States and the European Union.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
3.791 CNY
Average target price
5.661 CNY
Spread / Average Target
+49.33%
Consensus
  1. Stock Market
  2. Equities
  3. 2235 Stock
  4. News MicroTech Medical (Hangzhou) Co., Ltd.
  5. MicroTech Medical : Raises $234 Million in Tencent-Backed Hong Kong IPO Ahead of Tuesday Debut